![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ABBOTT ENROLLS FIRST PATIENT IN NEW CLINICAL TRIAL OF XIENCE V DRUG ELUTING STENT
ABBOTT ENROLLS FIRST PATIENT IN NEW CLINICAL TRIAL OF XIENCE V DRUG ELUTING STENT
Abbott announced Aug. 15 the enrollment of the first patient in its SPIRIT IV clinical trial for the continued evaluation of the safety and efficacy of the XIENCE(TM) V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in a more complex patient population. Medical News Today (http://www.medicalnewstoday.com/medicalnews.php?newsid=49578&nfid=rssfeeds)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct